Medicine treatment for 66 cases with reflux esophagitis resulting from postoperative cardiac carcinoma

Purpose:To observe medicine in the treatment of reflux esophagitis resulting from postoperative cardiac carcinoma. Methods:66 patients with reflux esophagitis resulging from postoperative cardiac carcinoma firstly were treated with ranitidine-motilium/cisapridc-sucralfatc combined regimen and the doses were 150 mg(bid),10-20 mg(tid),5-10 mg(tid),1 g(tid),respectively. The patients with no efficacy with combined regimen were treated ulteriorly with omeprazole, the dose was 20-40 mg(qd). Results:The clinical disappearing or improvement was attained by 51.6%(34/66) in patients treated with combined regimen, and by 93.8%(30/32) in patients (with no efficacy with combined ergimen) treated with omeprazole. Conclusions:Omeprazole could be efficacious for patients with reflux esophagitis resulting from postoperative cardiac carcinoma with no efficacy with ranitidinc-motilium/cisapridc-ulccrlmin combined regimen. Omeprazole as preferred therapy for reflux esophagitis resulting from postoperative cardiac carcinoma should be tested.